25902-89-0

Usage

Class

Organic compound, Pyrimidinone

Usage

Pharmaceutical and research applications

Potential activities

Biological and pharmacological

Current status

Under research for potential use as a pharmaceutical agent, further studies needed to fully understand its properties and potential applications.

InChI:InChI=1/C6H8N2O2/c1-4-3-7-6(9)8-5(4)10-2/h3H,1-2H3,(H,7,8,9)

Upstream product

• 7122-99-8 2-ethylsulfanyl-4-methoxy-5-methyl-pyrimidine 
• 13480-96-1 4-chloro-2-ethylsulfanyl-5-methyl-pyrimidine 
• 144782-14-9 5-methyl-4-(1,2,4-triazol-1-yl)-pyrimidin-2-(1H)-one 

Downstream Products

• 144867-38-9 1-(3-benzoyloxy-2-fluoropropyl)-4-methoxy-5-methyl-2-pyrimidone 
• 554-01-8 5-methylcytosin 
• 131652-75-0 C₁₀H₁₆N₄O₄ 
• 131652-76-1 1-[2-((R)-2-Imino-3-methyl-oxazolidin-4-yl)-ethyl]-5-methyl-1H-pyrimidine-2,4-dione 
• 126354-58-3 1-(2-Phosphonylmethoxyethyl)thymine dilithyum salt 
• 126354-30-1 N-(5-methyl-2-oxo-1H-pyrimidin-4-yl)benzamide 
• 897931-57-6 (S)-1-{2-[(diisopropoxyphosphoryl)methoxy]-3-(trityloxy)propyl}-4-methoxy-5-methylpyrimidin-2(1H)-one 
• 913274-67-6 (R)-1-{2-[(diisopropoxyphosphoryl)methoxy]-3-(trityloxy)propyl}-4-methoxy-5-methylpyrimidin-2(1H)-one 
• 913274-87-0 (S)-1-{2-[(diisopropoxyphosphoryl)methoxy]-3-(trityloxy)propyl}thymine 
• 913274-69-8 1-{2-[(diisopropoxyphosphoryl)methoxy]-3-(trityloxy)propyl}-4-methoxy-5-methylpyrimidin-2(1H)-one 
• 913274-62-1 (R)-1-[2-hydroxy-3-(trityloxy)propyl]-4-methoxy-5-methylpyrimidin-2(1H)-one 
• 113852-38-3 (S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]thymine 
• 113852-38-3 (R)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]thymine 
• 4160-72-9 1-methylthymine 

Relevant academic research and scientific papers

Process for the preparation of 5-substituted cytosines and other 4,5-disubstituted pyrimidin-2(1H)-ones, and intermediates arising in the course of this

Process for the preparation of 5-substituted cytosines and other 4,5-disubstituted pyrimidin-2(1H)-ones, and intermediates arising in the course of this The process for the preparation of compounds of the formula I, STR1 wherein compounds of the formula II STR2 are converted into an azole derivative of the formula III or an azine derivative of the formula IV STR3 which can subsequently be converted into a compound of the formula I using a nucleophile XH.